Search results
Results from the WOW.Com Content Network
1-bromo-2-chlorobenzene 1-bromo-3-chlorobenzene 1-bromo-4-chlorobenzene Molecular formula: BrC 6 H 4 Cl Molar mass: 191.45 g/mol CAS number: 694-80-4: 108-37-2: 106-39-8: ChemSpider: 12230: 13875377: 7518: PubChem CID: 12754: 7928: 7806: Properties Melting point: −13 °C (260 K) −22 °C (251 K) 63–67 °C (336–340 K) Boiling point: 203 ...
Phenylsilane is produced in two steps from Si(OEt) 4. In the first step, phenylmagnesium bromide is added to form Ph−Si(OEt) 3 via a Grignard reaction. Reduction of the resulting Ph−Si(OEt) 3 product with LiAlH 4 affords phenylsilane. [2] Ph−MgBr + Si(OEt) 4 → Ph−Si(OEt) 3 + MgBr(OEt) 4 Ph−Si(OEt) 3 + 3 LiAlH 4 → 4 Ph−SiH 3 + 3 ...
Chemical formula Synonyms CAS number C 10 H 16 N 2 O 8: Ethylenediaminetetraacetic acid (EDTA): 6381–92–6 C 12 H 22 O 11: sucrose: 57–50–1 C 18 H 29 O 3 S: sodium dodecyl benzenesulfonate: 2155–30–0
Download QR code; Print/export ... C 2 F 4 O −63.5 116 694-17-7 Arsine: AsH 3: −62.5 ... 80 430-61-5 1,1,1,2,4,4,4-Heptafluoro-2-butene ...
DAPT is a chemical compound used in the study of the Notch signaling pathway. [1] DAPT is a γ-secretase inhibitor. It indirectly inhibits Notch, which is a substrate for γ-secretase. [2] In a mouse model of Alzheimer's disease, DAPT reduces the levels of beta-amyloid. [3]
Hydrolysis of resulting diacetate affords "PhIO": [4] C 6 H 5 I + CH 3 CO 3 H + CH 3 CO 2 H → C 6 H 5 I(O 2 CCH 3) 2 + H 2 O C 6 H 5 I(O 2 CCH 3) 2 + H 2 O → C 6 H 5 IO + 2 CH 3 CO 2 H. The structure of iodosobenzene has been verified by crystallographically. [5] Related derivatives are also oligomeric. [6]
Download QR code; Print/export ... 96-80-0 3D model ... 145.246 g·mol −1 Appearance Colorless liquid Odor: Ammoniacal Density: 826 mg mL −1:
THC hemisuccinate (Δ 9-THC-O-hemisuccinate, Dronabinol hemisuccinate) is a synthetic derivative of tetrahydrocannabinol, developed in the 1990s.It is a water-soluble prodrug ester which is converted into THC inside the body, and was developed to overcome the poor bioavailability of THC when taken by non-inhaled routes of administration.